CareFusion Announces Launch

CareFusion (NYSE: CFN), a leading, global medical device company, today announced the national commercial launch of the AVAmax Vertebral Balloon, a minimally invasive device for use during kyphoplasty, a procedure for treating spinal compression fractures.

The AVAmax Vertebral Balloon represents a competitive breakthrough and is expected to enhance the affordability of spinal fracture procedures.

CareFusion's vertebral balloon product and related components cost up to 40 percent less than similar kyphoplasty products on the market today, making the procedure more cost effective and accessible to hospitals and outpatient surgery centers.